ArticleScientific reports2019

Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion.

Aowen Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.